Feb. 19, 2013
/PRNewswire/ -- University Hospitals (UH) in
, has received two significant gifts totaling
in support of the health system's
Discover the Difference Campaign.
to the UH Seidman Cancer Center and
Barbara Peterson Ruhlman
has made a gift of
to UH MacDonald Women's Hospital, which will be matched by a
gift from the Rainbow Babies & Children's Foundation.
UH Chief Executive Officer
Thomas F. Zenty III
announced the gifts to a crowd of more than 400 friends and supporters of the health system at its annual outreach event in
"Barbara and Kathy have both committed decades of dedicated service to University Hospitals as tireless volunteer leaders and generous benefactors," said Mr. Zenty. "Their extraordinary generosity will enable UH to further strengthen our nationally recognized programs in cancer and women's health and will have a lasting legacy for the patients treated at Seidman Cancer Center and MacDonald Women's Hospital."
These are the largest gifts since UH announced plans in
to continue its
Discover the Difference Campaign and pursue an expanded goal of
. The campaign – the largest in the history of
– has received unprecedented support, including more than 100,000 gifts from more than 60,000 individuals, foundations and corporations. This brings new gifts to UH since the
The Generosity of Mrs. Kathleen A. Coleman: A $7.5 Million Gift to UH Seidman Cancer Center
Mrs. Coleman has made this new
gift to further advance cancer clinical trials at UH Case Medical Center Seidman Cancer Center. She made previous gifts of
in honor of her late husband, Dr.
Lester E. Coleman
, bringing her lifetime giving to UH to
. Dr. Coleman, a scientist and the former CEO of Lubrizol Corporation, was diagnosed with advanced lung cancer at age 69 and participated in a clinical trial at Seidman Cancer Center.
In honor of Mrs. Coleman's significant donation, UH is establishing the Kathy and Les Coleman Clinical Trials Center at Seidman Cancer Center. Mrs. Coleman's gift will strengthen multiple aspects of the program, from expediting drug development to advancing diagnostic technology and developing new cancer treatments. The gift will support the expansion of the renowned clinical research program and is earmarked for early stage clinical trials, new technology and research equipment as well as patient education on the importance of clinical trials participation.